✦ LIBER ✦

Selecting Against S1P3 Enhances the Acute Cardiovascular Tolerability of 3-(N-Benzyl)aminopropylphosphonic Acid S1P Receptor Agonists.

✍ Scribed by Jeffrey J. Hale; et al. et al.

Publisher: John Wiley and Sons
Year: 2004
Weight: 18 KB
Volume: 35
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200443178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of 3-Arylpropionic Acids as Po

Discovery of 3-Arylpropionic Acids as Potent Agonists of Sphingosine-1-phosphate Receptor-1 (S1P1) with High Selectivity Against All Other Known S1P Receptor Subtypes.

✍ Lin Yan; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 14 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Design and Synthesis of Conformationally

Design and Synthesis of Conformationally Constrained 3-(N-alkylamino)propylphosphonic Acids as Potent Agonists of Sphingosine-1-phosphate (S1P) Receptors.

✍ Lin Yan; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 13 KB 👁 2 views

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views